Once daily lithium in the prophylaxis of mood disorders

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Therapeutics

Background:

• Lithium is a key mood stabilizer for bipolar disorder.
• Optimal dosing strategies for lithium prophylaxis remain under investigation.
• Understanding the efficacy and safety of different lithium dosing schedules is crucial for patient management.

Purpose of the Study:

• To compare the utility, safety, and efficacy of once daily (OD) versus divided dose (DD) lithium therapy.
• To evaluate the impact of lithium dosing frequency on mood disorder prophylaxis.
• To analyze serum lithium levels and affective episode frequency based on dosing schedule.

Main Methods:

• Retrospective chart review of 66 patients meeting DSM-III-R criteria for mood disorders.
• Patients were categorized into OD lithium (n=31) and DD lithium (n=35) groups.
• Groups were matched on sociodemographic and clinical variables; total daily dose was similar.

Main Results:

• The OD lithium group tended to exhibit higher serum lithium levels.
• The DD lithium group tended to experience a greater number of affective episodes.
• No significant differences in safety were explicitly detailed, but efficacy trends emerged.

Conclusions:

• Once daily lithium dosing may offer an advantage in mood disorder prophylaxis compared to divided doses.
• Higher serum lithium levels in the OD group did not appear to correlate with increased adverse events in this review.
• Further research is warranted to confirm these findings and elucidate optimal lithium dosing strategies.